Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11746157 PSMA binding agents and uses thereof

Patent 11746157 was granted and assigned to Janssen Biotech on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Janssen Biotech

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

John Michael Jones

Colleen Kane

Glenn Mark Anderson

Tammy Bush

Rosa Maria Fernandes Cardoso

Derrick Lemon Domingo

Bethany Kay Mattson

Richard Stephen Tawadros

...

Date of Patent

September 5, 2023

Patent Application Number

16418328

Date Filed

May 21, 2019

Patent Citations

US Patent 10844122 Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof

US Patent 8748356 Methods for use in human-adapting monoclonal antibodies

US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs

US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands

Patent Primary Examiner

Meera Natarajan

CPC Code

The present invention relates to antibodies specifically binding PSMA or PSMA and CD3, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11746157 PSMA binding agents and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool